Quick estimate

Cost and timeline,
with and without
a hybrid arm.

Set your phase and therapeutic area to see how a hybrid control arm changes recruited patients, duration, and control cost. Open the assumptions to see the math. These figures are illustrative, not a quote.

01The model

A traditional RCT, next to a hybrid arm.

A hybrid control arm reduces and strengthens the control arm by replacing a share of recruited controls with external ones. It does not fully replace the placebo arm, which regulators still generally require.

Trial phase
Therapeutic area

Note-derived subjective scales. Our first wedge.

Control patients to recruit180from 180
Est. control cost$9.4M
Recruitment14 mo
Full control arm · all recruitedRecruited
Built from real-world records. Item-level traceable.

Illustrative

Traditional RCT
Control patients to recruit180
Recruitment duration14 mo
Estimated control cost$9.4M
Hybrid with Sapien
Control patients to recruit90
Recruitment duration10 mo
Estimated control cost$5.3M
~44%lower control cost
4 mofaster recruitment
90controls replaced with data

Illustrative, not a quote. Actual figures depend on your protocol, indication, and available real-world data.

Model your own program →

Turn an estimate into
a feasibility map.

Bring your protocol. We map it against available real-world data and show the path a hybrid control arm opens toward approval.